Torii Pharmaceutical Co., Ltd.

TSE:4551 Stock Report

Market Cap: JP¥139.8b

Torii Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 4551?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders22,3370.0796%
Employee Share Scheme246,1000.877%
Institutions5,841,37420.8%
General Public6,564,42823.4%
Public Companies15,398,80054.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 76.36% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
54.9%
Japan Tobacco Inc.
15,398,800JP¥76.7b0%no data
4.91%
Effissimo Capital Management Pte Ltd.
1,379,300JP¥6.9b-17.8%0.47%
3.39%
The Tachibana Securities Co., Ltd., Asset Management Arm
952,900JP¥4.7b0%6.04%
1.64%
The Vanguard Group, Inc.
459,816JP¥2.3b5.48%no data
1.46%
Zennor Asset Management LLP
409,200JP¥2.0b0%1.74%
1.44%
Amundi Asset Management SAS
403,360JP¥2.0b0.07%no data
1.16%
Nomura Asset Management Co., Ltd.
325,900JP¥1.6b-1.39%no data
1.09%
Norges Bank Investment Management
305,000JP¥1.5b0%no data
0.88%
Torii Pharmaceutical Co., Ltd. ESOP
246,100JP¥1.2b0%no data
0.87%
Dimensional Fund Advisors LP
242,914JP¥1.2b-0.07%no data
0.77%
Goldman Sachs Group, Investment Banking and Securities Investments
216,100JP¥1.1b0%no data
0.77%
Nomura Holdings Inc, Securities & Investment Arm
215,300JP¥1.1b0%0.03%
0.66%
Nikko Asset Management Co., Ltd.
185,100JP¥921.8m-1.23%no data
0.63%
BlackRock, Inc.
177,317JP¥883.0m1.79%no data
0.52%
Daiwa Asset Management Co., Ltd.
144,900JP¥721.6m-2.36%no data
0.43%
Polar Capital Holdings Plc
120,000JP¥597.6m0%0.01%
0.23%
Mitsubishi UFJ Asset Management Co., Ltd.
64,800JP¥322.7m-14.3%no data
0.19%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
52,565JP¥261.8m-7.4%no data
0.089%
ASPOMA Asset Management AG
25,000JP¥124.5m0%1.77%
0.084%
Charles Schwab Investment Management, Inc.
23,692JP¥118.0m-0.34%no data
0.069%
Goldman Sachs Asset Management, L.P.
19,400JP¥96.6m6.59%no data
0.067%
PGIM, Inc.
18,700JP¥93.1m0%no data
0.065%
Goichi Matsuda
18,231JP¥90.8m0%no data
0.057%
Asset Management One Co., Ltd.
15,900JP¥79.2m-1.24%no data
0.055%
Sumitomo Mitsui Trust Asset Management Co., Ltd.
15,500JP¥77.2m3.33%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 18:55
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Torii Pharmaceutical Co., Ltd. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hidemaru YamaguchiCitigroup Inc
Kazuaki HashiguchiDaiwa Securities Co. Ltd.
Takashi AkahaneTokai Tokyo Intelligence Laboratory Co., Ltd.